These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7913618)

  • 1. Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins.
    Ignarro LJ
    Adv Pharmacol; 1994; 26():35-65. PubMed ID: 7913618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins.
    Ignarro LJ
    Semin Hematol; 1989 Jan; 26(1):63-76. PubMed ID: 2564216
    [No Abstract]   [Full Text] [Related]  

  • 3. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling.
    Ignarro LJ
    Pharmacol Toxicol; 1990 Jul; 67(1):1-7. PubMed ID: 1975691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide. A novel signal transduction mechanism for transcellular communication.
    Ignarro LJ
    Hypertension; 1990 Nov; 16(5):477-83. PubMed ID: 1977698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism.
    Ignarro LJ
    Blood Vessels; 1991; 28(1-3):67-73. PubMed ID: 1672101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins.
    Ignarro LJ; Ballot B; Wood KS
    J Biol Chem; 1984 May; 259(10):6201-7. PubMed ID: 6144676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system.
    Murad F
    Adv Pharmacol; 1994; 26():19-33. PubMed ID: 7913616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and cytosolic guanylate cyclase: components of an intercellular signalling system.
    Böhme E; Schmidt HH
    Z Kardiol; 1989; 78 Suppl 6():75-9. PubMed ID: 2575829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms.
    Ignarro LJ; Adams JB; Horwitz PM; Wood KS
    J Biol Chem; 1986 Apr; 261(11):4997-5002. PubMed ID: 2870064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
    Ishii K; Chang B; Kerwin JF; Wagenaar FL; Huang ZJ; Murad F
    J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanylate cyclase from bovine lung. Evidence that enzyme activation by phenylhydrazine is mediated by iron-phenyl hemoprotein complexes.
    Ignarro LJ; Wood KS; Ballot B; Wolin MS
    J Biol Chem; 1984 May; 259(9):5923-31. PubMed ID: 6143758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
    Severina IS
    Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism.
    Ignarro LJ
    Biochem Soc Trans; 1992 May; 20(2):465-9. PubMed ID: 1356858
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.
    Pou S; Pou WS; Rosen GM; el-Fakahany EE
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):547-52. PubMed ID: 1671745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic stimulation of cyclic GMP formation requires NO-dependent activation of cytosolic guanylate cyclase in rat pinealocytes.
    Spessert R; Layes E; Vollrath L
    J Neurochem; 1993 Jul; 61(1):138-43. PubMed ID: 8099948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.